BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6196789)

  • 21. [The antineoplastic effect of interferon].
    Olesen BK; Ernst P
    Ugeskr Laeger; 1986 Feb; 148(7):375-7. PubMed ID: 2420053
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC).
    Oldham RK; Lewko WM; Good RW; Sharp E
    In Vivo; 1994; 8(5):653-63. PubMed ID: 7537108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expectations in the clinical application of human-recombinant cytokines. 1) Present status of clinical application of interferons].
    Taguchi T
    Nihon Rinsho; 1988 May; 46(5):1085-92. PubMed ID: 2457721
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon: current status.
    Mayer DK; Smalley RV
    Oncol Nurs Forum; 1983; 10(4):14-9. PubMed ID: 6195644
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon.
    Katrak M
    Nurs Times; 1983 Jul 6-12; 79(27):53-4. PubMed ID: 6194515
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interferon].
    Tigaud JM; Duarte A; Psyche S; Droz JP
    Rev Infirm; 1991 Dec; 41(19):32-3. PubMed ID: 1722901
    [No Abstract]   [Full Text] [Related]  

  • 27. Interferon.
    Horoszewicz JS
    Prostate; 1984; 5(2):213-9. PubMed ID: 6200869
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mechanisms of the antitumor effects interferons].
    Adam Z
    Vnitr Lek; 1994 Jan; 40(1):56-8. PubMed ID: 7511261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problems in the clinical evaluation of interferon].
    Zanussi C
    Ann Ist Super Sanita; 1987; 23(4):779-85. PubMed ID: 2454600
    [No Abstract]   [Full Text] [Related]  

  • 30. The interferons.
    Toy JL
    Clin Exp Immunol; 1983 Oct; 54(1):1-13. PubMed ID: 6193915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferons in cancer treatment: yesterday, today and tomorrow].
    Tanneberger S
    Z Arztl Fortbild (Jena); 1994 Jun; 88(5-6):381-92. PubMed ID: 7522380
    [No Abstract]   [Full Text] [Related]  

  • 32. Abstracts. The 1986 ISIR-TNO meeting on the interferon system. Espoo, 7-12 September 1986.
    J Interferon Res; 1986 Sep; 6 Suppl 1():1-152. PubMed ID: 2426371
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in interferon.
    Finter NB
    Practitioner; 1982 Oct; 226(1372):1729-34. PubMed ID: 6184707
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-tumor effects of interferon (author's transl)].
    Sun Y
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):556-8. PubMed ID: 6176299
    [No Abstract]   [Full Text] [Related]  

  • 35. The interferons.
    Skalla K
    Semin Oncol Nurs; 1996 May; 12(2):97-105. PubMed ID: 8727797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon therapy.
    World Health Organ Tech Rep Ser; 1982; 676():1-28. PubMed ID: 6178225
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-new wonder drug or old laboratory curiosity?
    Tannock GA
    Med J Aust; 1981 Oct; 2(7):352-6. PubMed ID: 6170870
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferons: in pursuit of the promise.
    Borden EC
    Prog Clin Biol Res; 1983; 132E():287-96. PubMed ID: 6196788
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospects for the medical use of interferon in 1984.
    Postic B; Arroyo JC
    Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.